Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World August 21, 2013 Phillip Broadwith	Two way traffic for Chinese drug licensing Chinese companies have trailed behind their Western counterparts in developing innovative new drugs. Very few of those inventions have been considered useful enough to be licensed by western companies. However, that appears to be changing.
BusinessWeek December 13, 2004 Bruce Einhorn	Go East, Big Pharma Drugmakers are expanding in China, but patents are still a worry.
Chemistry World June 2007 Derek Lowe	Opinion: In the Pipeline A medicinal chemist experienced in pre-clinical drug discovery sets the record straight about pharmaceutical patents on traditional medicines.
Chemistry World May 2007 Lisa Melton	Chinese Medicine in Western Packaging The past decade has seen a global awakening to the truly curative powers of many ancient medicines, from black bear bile to the Asian plant Epimedium.
Pharmaceutical Executive December 1, 2010 Zhu Shen	China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda
Chemistry World November 10, 2015 Hepeng Jia	China's first science Nobel prize exposes anxiety on research Artemisinin saves tens of thousands of lives every year. The story of its discovery has been debated for decades in China. The awarding of the medicine Nobel prize has only served to reopen old wounds.
The Motley Fool March 21, 2007 Brian Lawler	New Indication for Pain Pain Therapeutics brings a new drug into the clinic. When drug companies attempt to bring new drugs that are outside of their core competencies to market, investors always need to be wary.
Pharmaceutical Executive June 1, 2005 Peter J. Pitts	Opinion: Uncle Sam, MD Is having the government pursue a patent the best way of placing important discoveries in the public domain? It depends. Is putting the government in control of drug development in the best interests of public health? No.
Chemistry World June 10, 2011 Hepeng Jia	Traditional Chinese medicines hampered by EU regulations The European Commission stipulated that traditional Chinese medicines must be registered, before the end of April 2011, prior to being sold in the European Union. But with this deadline passed, very few TCMs have been successfully registered.
Chemistry World July 3, 2014 Maria Burke	Renewed focus on dementia checked by drug challenges The risks and barriers for companies working in dementia are huge, but so too, potentially, are the rewards, says Simon Ridley, head of research at Alzheimer's Research UK.
HBS Working Knowledge April 21, 2014 Carmen Nobel	Bio-piracy: When Western Firms Usurp Eastern Medicine Raj Choudhury and Tarun Khanna examine the history of herbal patent applications, challenging a stereotype that characterizes Western firms as innovators and emerging markets as imitators.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
Chemistry World December 2009	Column: In the pipeline Is the pharmaceutical industry churning out copycat versions of existing therapies? The author dispels a few myths about 'me-too' drugs
Bio-IT World June 17, 2004 Hope Melville	Is It Safe? Think the safe harbor provision in patent law lets you use patented compounds in all preclinical-phase research? Think again.
Chemistry World June 17, 2015 James Urquhart	Promising compound offers single dose knock-out for malaria Ian Gilbert and colleagues, working with the Medicines for Malaria Venture, have found a compound dubbed DDD107498 which kills Plasmodium falciparum -- the species responsible for most dangerous form of malaria.
Linux Journal May 1, 2002 Lawrence Rosen	The Role of Standards in Open Source And, on how new standards are often compatible with free and open-source licensing...
Chemistry World January 15, 2008 Hepeng Jia	Huge Project to Boost Chinese Drug Development The Chinese government has agreed a multi-billion drug development funding program to boost innovation in its generics-dominated pharmaceutical sector.
InternetNews January 18, 2008	Microsoft Accused of Patent Violation in China A small Chinese high-tech firm is suing Microsoft because it says the software giant stole technology that allows Internet users to type Chinese characters. Microsoft countered the claim on Friday.
Chemistry World January 26, 2009 Jia & Yuan	China pushes for higher quality patents In an effort to boost the quality of patent applications, and encourage Chinese firms to obtain international patents, China has revised its patent law.
Pharmaceutical Executive August 1, 2005 Jill Wechsler	Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development.
Pharmaceutical Executive September 1, 2010	Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP.
Pharmaceutical Executive May 1, 2005 Margaret Buck	Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing.
InternetNews November 16, 2005 Susan Kuchinskas	PubPat Claims 'Prior Art' on JPEG Patent The Public Patent Foundation is asking the U.S. Patent office to take another look at the data compression format.
Inc. July 24, 2002 Jennifer A. Redmond	Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make.
The Motley Fool September 12, 2005 M.D. Mitchell	Big Problems for Big Pharma Creating new drugs is never easy, but the companies that excel in three key areas are the ones for investors to watch.
Bio-IT World June 17, 2004 John Garvey	Rational Decisions As companies in the computationally guided rational drug design sector mature, they should be more sure of the boundaries that surround their proprietary technologies.
Chemistry World January 2009 Derek Lowe	Column: In the pipeline The author discusses the age-old tradition of passing the buck in drug development.
Linux Journal January 1, 2007 Jon Hall	Beachhead - Ode to Joy Thoughts on the purpose of patents, the problems with software patents, and how patents impacted the piano.
The Motley Fool March 31, 2008 Dave Mock	China Faces a Major Wireless Test With the Beijing Olympics quickly approaching, the Chinese government is hoping that everyone will see and hear what China can do in mobile communications by promoting the launch of its homegrown third-generation wireless technology.
Chemistry World October 31, 2012 Andrew Turley	Chemists contribute to prior art hunt Do you know some chemistry? Do you have spare time? Then it might be that you can make money stress testing the patent literature with Article One Partners, a crowdsourcing website.
InternetNews December 1, 2004 Susan Kuchinskas	Microsoft Fights to Keep China Business Microsoft is fighting to hold onto a multi-million dollar deal with the municipal government of Beijing.
Bio-IT World November 19, 2004 Lentini & Bent	Intellectual Property: Patents and Genomic Medicine Patents, so critical to encouraging investment in developing new technologies, threaten to become a legal and economic minefield that could prevent effective commercial exploitation of genomics.
InternetNews April 28, 2010	Microsoft, HTC Widen Patent Agreement In expanded patent agreement, Microsoft will provide patent coverage for its intellectual property in use in HTC's Android phones.
Managed Care January 2005	Cost of Coverage Forces Search For 'Alternatives' Among those turning to herbal remedies because of the cost of conventional medicine, 54% did so without either telling a conventional medical professional or disclosing use of complementary and alternative medicine during a medical visit.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
American Family Physician December 15, 2006	Tips for Using Medicines Wisely A patient guide and suggestions for safe medicine use.
Chemistry World November 16, 2009 Hepeng Jia	Chinese NASDAQ brings little to chemicals industry Similar to the US NASDAQ, most of the listed firms in the Chinese GEM are technology-oriented companies. Classified by industry, electronics and pharmaceutical manufacturers are the biggest groups
Chemistry World October 11, 2007 Hepeng Jia	China's Drug Industry Set to Take Off Producing cheap drugs for the developing world could allow Chinese pharmaceutical firms to capture a bigger share of the international market, industry experts suggest.
BusinessWeek November 8, 2004	Haier: "Local Resources" Are Key Overseas CEO and Chairman Zhang Ruimin recently spoke with Beijing Bureau Chief Dexter Roberts at company headquarters in Qingdao in China's Shandong province. Following are edited excerpts of their conversation.
American Family Physician September 1, 2006	Getting Your Child to Take Medicine What to do if you child won't take his/her medicine.
The Motley Fool July 26, 2007 Brian Orelli	Barr Gets Sued, Again This is starting to be a bad habit at Barr Pharmaceutical. The drug maker has just been sued for the third time in as many weeks. The latest one is by Schering-Plough, over patent infringement of its brain cancer treatment drug.
The Motley Fool February 26, 2009 Brian Orelli	Big Blue Struts Its Stimulus Stuff The company announces that it had signed up four hospital groups in the U.S. to use its electronic medical records systems, after the stimulus bill contained $19 billion in grants and incentives to encourage doctors and hospitals to invest in electronic medical records.
BusinessWeek September 4, 2008 Pete Engardio	Chinese Scientists Build Big Pharma Back Home In a reverse migration, U.S.-trained scientists are setting up biotech startups, contract-research companies, and university labs on the mainland.
The Motley Fool May 1, 2007 Brian Lawler	Cardiome Plays Dealmaker Cardiome signs a deal to develop one of Eli Lilly's drug candidates. Investors, take note.
The Motley Fool April 22, 2011 Sean Williams	Pharma's Most Perilous Pipelines Patent expirations expose weaknesses for these Wall Street darlings.
The Motley Fool August 13, 2010 Brian Orelli	Already a Slippery Slope for Eli Lilly The company gets a whiff of what its patent cliff might be like.
InternetNews December 15, 2005 Susan Kuchinskas	Yahoo Bows to JPEG Patent Forgent rocked the tech industry when it claimed a patent covering JPEGs. It looks like the patent may stick as Yahoo has entered into a patent licensing agreement covering its use of Forgent's data-compression technology.
IndustryWeek August 1, 2006	Patents: Eleven Issues To Consider... How patent savvy are you?
Chemistry World August 23, 2012 Dean Baker	Monopoly money It is remarkable that the system of patent support for prescription drug research has not become more of a policy issue.